In addition, survival curve analysis demonstrated a dramatically worse overall survival for ovarian cancer patients who had high expression of FOXK1, indicating that expression of FOXK1 was correlated with poor prognosis in ovarian cancer. This evidence concerns the gene FOXK1 and ovarian cancer.